Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
eNq1mE1z2jAQhu/8Co8PvWHjEBLS2jAtTVpmkiklMO30wgh7CaJGcvTBR399ZQwNZOShEeiIZb+73l09enHYXs1TZwGMY0oiN/BqrgMkpgkmT5E7HNxVm267VQlnaIH2brv2al5w4TpxijiP3HzVGwMi3Pv5cP8Z1PPA3FbFCel4BrE4uE8KnHpfEZ8+oCy/xwkXFCfOHMSUJpGbSbG56oRcMJVFa0nZb56hGEJ/e2V/dTa63L8e+rnYf6hKDuwekSetKBAjzVgyBkR0kIAnytYl+daNtDHvA6eSxdBDYtpjdIETSLQhJijlYBRkskwegS1SEHkQrbg/i+fcSBzN0KoPz1190h/VakesRLVWDa4bzSC4uqrXLoKaUSi2Vyp9F9RL+FnGktHFTbNRrzV8ID4m+SJHVQFcUC6AUQKGzepRJlBqqU2Ydw4nzVIcBs9HxyHBPEvR2pvxzLRUiCG1DEzxwN6L5G8wYIpQqarZK30i09R/Y9bDLT8sZZzjqUOlmkg9Ru76poXoUCJgVd5RM/KJ1XYWMfDzyf55tQH/LfTkOMWxKeMUhaTa4sN+txxxVunwCXEYMnt4+IFJQpf8/NjZb7Ol7LMNObWiqiNB3pKroNEw3lW/VNtKzqBbyWgGvgIS5qdwpksm9FTCqDHVS+2G1N58bqwRjVEKJeaoakgfNZg7L2dt9O1tq2JBK/rldmA6L98lsPXj5qdWGifRfqfN6GwD+WpAj+VebOUoG6nEmzf1y3donn3YGe/I0GQXolY8tmR67kyFyPh7318ul94U8SpHqp7ehL3hoGhra3GOeigqv7TX3v8CK7ahsFEFkS2lPi6O2rf11XQzHzMWp5rl7fNbU66NIZiEE3pRcN8anbu35wf+i1O2lnbvgDn2wmxcLRKYElvmSo71pD71iFGtJXcKdOLbZIJLPtWUjmboF5+JWpXQzz8RtSp/AYuMH7E=
HhPuJGf38HqNYaTD